<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33635895</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>2</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Cloning and high-level expression of monomeric human superoxide dismutase 1 (SOD1) and its interaction with pyrimidine analogs.</ArticleTitle><Pagination><StartPage>e0247684</StartPage><MedlinePgn>e0247684</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0247684</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0247684</ELocationID><Abstract><AbstractText>Superoxide dismutase 1 (SOD1) is known to be involved in the pathogenesis of Amyotrophic Lateral Sclerosis (ALS) and is therefore considered to be an important ALS drug target. Identifying potential drug leads that bind to SOD1 and characterizing their interactions by nuclear magnetic resonance (NMR) spectroscopy is complicated by the fact that SOD1 is a homodimer. Creating a monomeric version of SOD1 could alleviate these issues. A specially designed monomeric form of human superoxide dismutase (T2M4SOD1) was cloned into E. coli and its expression significantly enhanced using a number of novel DNA sequence, leader peptide and growth condition optimizations. Uniformly 15N-labeled T2M4SOD1 was prepared from minimal media using 15NH4Cl as the 15N source. The T2M4SOD1 monomer (both 15N labeled and unlabeled) was correctly folded as confirmed by 1H-NMR spectroscopy and active as confirmed by an in-gel enzymatic assay. To demonstrate the utility of this new SOD1 expression system for NMR-based drug screening, eight pyrimidine compounds were tested for binding to T2M4SOD1 by monitoring changes in their 1H NMR and/or 19F-NMR spectra. Weak binding to 5-fluorouridine (FUrd) was observed via line broadening, but very minimal spectral changes were seen with uridine, 5-bromouridine or trifluridine. On the other hand, 1H-NMR spectra of T2M4SOD1 with uracil or three halogenated derivatives of uracil changed dramatically suggesting that the pyrimidine moiety is the crucial binding component of FUrd. Interestingly, no change in tryptophan 32 (Trp32), the putative receptor for FUrd, was detected in the 15N-NMR spectra of 15N-T2M4SOD1 when mixed with these uracil analogs. Molecular docking and molecular dynamic (MD) studies indicate that interaction with Trp32 of SOD1 is predicted to be weak and that there was hydrogen bonding with the nearby aspartate (Asp96), potentiating the Trp32-uracil interaction. These studies demonstrate that monomeric T2M4SOD1 can be readily used to explore small molecule interactions via NMR.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>LeVatte</LastName><ForeName>Marcia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipfert</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>Dipankar</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Mechanical Engineering, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kovalenko</LastName><ForeName>Andriy</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5033-4314</Identifier><AffiliationInfo><Affiliation>Department of Mechanical Engineering, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nanotechnology Research Centre, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wishart</LastName><ForeName>David Scott</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0002-3207-2434</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computing Science, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>4HK400G5UO</RegistryNumber><NameOfSubstance UI="D001976">Bromouracil</NameOfSubstance></Chemical><Chemical><RegistryNumber>4K0M952561</RegistryNumber><NameOfSubstance UI="C001943">5-fluorouridine</NameOfSubstance></Chemical><Chemical><RegistryNumber>8DUH1N11BX</RegistryNumber><NameOfSubstance UI="D014364">Tryptophan</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>KEY8PG1BRC</RegistryNumber><NameOfSubstance UI="C006824">5-bromouridine</NameOfSubstance></Chemical><Chemical><RegistryNumber>RMW9V5RW38</RegistryNumber><NameOfSubstance UI="D014271">Trifluridine</NameOfSubstance></Chemical><Chemical><RegistryNumber>WHI7HQ7H85</RegistryNumber><NameOfSubstance UI="D014529">Uridine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001976" MajorTopicYN="N">Bromouracil</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006860" MajorTopicYN="N">Hydrogen Bonding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056004" MajorTopicYN="N">Molecular Dynamics Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066244" MajorTopicYN="N">Proton Magnetic Resonance Spectroscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014271" MajorTopicYN="N">Trifluridine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014364" MajorTopicYN="N">Tryptophan</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014529" MajorTopicYN="N">Uridine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>26</Day><Hour>17</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33635895</ArticleId><ArticleId IdType="pmc">PMC7909654</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0247684</ArticleId><ArticleId IdType="pii">PONE-D-20-39700</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Valentine JS, Doucette PA, Zittin Potter S. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem. 2005;74: 563&#x2013;593. 10.1146/annurev.biochem.72.121801.161647</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.72.121801.161647</ArticleId><ArticleId IdType="pubmed">15952898</ArticleId></ArticleIdList></Reference><Reference><Citation>Amyotrophic Lateral Sclerosis online Database&#x2014;ALSoD. [cited 30 Nov 2020]. Available: https://alsod.ac.uk/.</Citation></Reference><Reference><Citation>Shibata N, Hirano A, Kobayashi M, Sasaki S, Takeo K, Matsumoto S, et al.. Cu Zn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis. Neurosci Lett. 1994;179: 149&#x2013;152. 10.1016/0304-3940(94)90956-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(94)90956-3</ArticleId><ArticleId IdType="pubmed">7845611</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al.. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (80-). 2006;314: 130&#x2013;133. 10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotunno MS, Bosco DA. An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis. Front Cell Neurosci. 2013;7: 253. 10.3389/fncel.2013.00253</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00253</ArticleId><ArticleId IdType="pmc">PMC3863749</ArticleId><ArticleId IdType="pubmed">24379756</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino M, Amori I, Pesaresi MG, Ferri A, Nencini M, Carr&#xec; MT. Cysteine 111 affects aggregation and cytotoxicity of mutant Cu,Zn-superoxide dismutase associated with familial amyotrophic lateral sclerosis. J Biol Chem. 2008;283: 866&#x2013;874. 10.1074/jbc.M705657200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M705657200</ArticleId><ArticleId IdType="pmc">PMC2842925</ArticleId><ArticleId IdType="pubmed">18006498</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, Shi Y, Furukawa Y, Zhai H, Fu R, Liu E, et al.. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc Natl Acad Sci U S A. 2006;103: 7142&#x2013;7147. 10.1073/pnas.0602046103</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0602046103</ArticleId><ArticleId IdType="pmc">PMC1447523</ArticleId><ArticleId IdType="pubmed">16636275</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray SS, Nowak RJ, Brown RH, Lansbury PT. Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation. Proc Natl Acad Sci U S A. 2005;102: 3639&#x2013;3644. 10.1073/pnas.0408277102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0408277102</ArticleId><ArticleId IdType="pmc">PMC553303</ArticleId><ArticleId IdType="pubmed">15738401</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright GSA, Antonyuk SV, Kershaw NM, Strange RW, Samar Hasnain S. Ligand binding and aggregation of pathogenic SOD1. Nat Commun. 2013;4: 1&#x2013;10. 10.1038/ncomms2750</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2750</ArticleId><ArticleId IdType="pmc">PMC3644087</ArticleId><ArticleId IdType="pubmed">23612299</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinge VK, Blinov N, Roy D, Wishart DS, Kovalenko A. The role of hydration effects in 5-fluorouridine binding to SOD1: insight from a new 3D-RISM-KH based protocol for including structural water in docking simulations. J Comput Aided Mol Des. 2019;33: 913&#x2013;926. 10.1007/s10822-019-00239-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10822-019-00239-3</ArticleId><ArticleId IdType="pubmed">31686367</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare SD, Caplow M, Dokholyan NV. The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2004;101: 15094&#x2013;15099. 10.1073/pnas.0406650101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0406650101</ArticleId><ArticleId IdType="pmc">PMC524068</ArticleId><ArticleId IdType="pubmed">15475574</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer WF, Fridovich I, Mullenbach GT, Hallewell R. Examination of the role of arginine-143 in the human copper and zinc superoxide dismutase by site-specific mutagenesis. J Biol Chem. 1987;262: 11182&#x2013;11187. Available: https://europepmc.org/article/med/3112154. </Citation><ArticleIdList><ArticleId IdType="pubmed">3112154</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L, Bertini I, Viezzoli MS, Argese E, Orsega EF, Choi Ying Chiu, et al.. Tuning the activity of Cu,Zn superoxide dismutase through site-directed mutagenesis: A relatively active monomeric species. J Biol Inorg Chem. 1997;2: 295&#x2013;301. 10.1007/s007750050135</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s007750050135</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L, Benedetto M, Bertini I, Del Conte R, Piccioli M, Viezzoli MS. Solution structure of reduced monomeric Q133M2 copper, zinc superoxide dismutase (SOD). Why is SOD a dimeric enzyme? Biochemistry. 1998;37: 11780&#x2013;11791. 10.1021/bi9803473</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi9803473</ArticleId><ArticleId IdType="pubmed">9718300</ArticleId></ArticleIdList></Reference><Reference><Citation>Getzoff ED, Cabelli DE, Fisher CL, Parge HE, Viezzoli MS, Banci L, et al.. Faster superoxide dismutase mutants designed by enhancing electrostatic guidance. Nature. 1992;358: 347&#x2013;351. 10.1038/358347a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/358347a0</ArticleId><ArticleId IdType="pubmed">1353610</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Guest WC, Yanai A, Pokrishevsky E, O&#x2019;Neill MA, Gibbs E, et al.. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc Natl Acad Sci U S A. 2011;108: 16398&#x2013;16403. 10.1073/pnas.1102645108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1102645108</ArticleId><ArticleId IdType="pmc">PMC3182705</ArticleId><ArticleId IdType="pubmed">21930926</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallewell RA, Imlay KC, Lee P, Fong NM, Gallegos C, Getzoff ED, et al.. Thermostabilization of recombinant human and bovine CuZn superoxide dismutases by replacement of free cysteines. Biochem Biophys Res Commun. 1991;181: 474&#x2013;480. 10.1016/s0006-291x(05)81443-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0006-291x(05)81443-3</ArticleId><ArticleId IdType="pubmed">1958215</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinman HM. Bacteriocuprein superoxide dismutase of Photobacterium leignathi. Isolation and sequence of the gene and evidence for a precursor form. J Biol Chem. 1987;262: 1882&#x2013;1887.</Citation><ArticleIdList><ArticleId IdType="pubmed">3805055</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning: A laboratory manual. Evans GA, editor. New York: Cold Spring Harbor Laboratory Press; 1989.</Citation></Reference><Reference><Citation>Koshland D, Botstein D. Secretion of beta-lactamase requires the carboxy end of the protein. Cell. 1980;20: 749&#x2013;760. 10.1016/0092-8674(80)90321-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(80)90321-9</ArticleId><ArticleId IdType="pubmed">6448092</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xe4;gger H. Tricine-SDS-PAGE. Nat Protoc. 2006;1: 16&#x2013;22. 10.1038/nprot.2006.4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2006.4</ArticleId><ArticleId IdType="pubmed">17406207</ArticleId></ArticleIdList></Reference><Reference><Citation>Beauchamp C, Fridovich I. Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels. Anal Biochem. 1971;44: 276&#x2013;287. 10.1016/0003-2697(71)90370-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-2697(71)90370-8</ArticleId><ArticleId IdType="pubmed">4943714</ArticleId></ArticleIdList></Reference><Reference><Citation>ExPASy&#x2014;ProtParam tool. [cited 30 Nov 2020]. Available: https://web.expasy.org/protparam/.</Citation></Reference><Reference><Citation>Adams RW, Holroyd CM, Aguilar JA, Nilsson M, Morris GA. &#x201c;Perfecting&#x201d; WATERGATE: Clean proton NMR spectra from aqueous solution. Chem Commun. 2013;49: 358&#x2013;360. 10.1039/c2cc37579f</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c2cc37579f</ArticleId><ArticleId IdType="pubmed">23192194</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart DS, Bigam CG, Yao J, Abildgaard F, Dyson HJ, Oldfield E, et al.. 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR. 1995;6: 135&#x2013;140. 10.1007/BF00211777</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00211777</ArticleId><ArticleId IdType="pubmed">8589602</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer M, Meyer B. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew Chemie&#x2014;Int Ed. 1999;38: 1784&#x2013;1788. 10.1002/(SICI)1521-3773(19990614)38:12&amp;lt;1784::AID-ANIE1784&amp;gt;3.0.CO;2-Q</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1521-3773(19990614)38:12&amp;lt;1784::AID-ANIE1784&amp;gt;3.0.CO;2-Q</ArticleId><ArticleId IdType="pubmed">29711196</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris GM, Ruth H, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al.. Software news and updates AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 2009;30: 2785&#x2013;2791. 10.1002/jcc.21256</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.21256</ArticleId><ArticleId IdType="pmc">PMC2760638</ArticleId><ArticleId IdType="pubmed">19399780</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoete V, Cuendet MA, Grosdidier A, Michielin O. SwissParam: A fast force field generation tool for small organic molecules. J Comput Chem. 2011;32: 2359&#x2013;2368. 10.1002/jcc.21816</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.21816</ArticleId><ArticleId IdType="pubmed">21541964</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, MacKerell AD. CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR data. J Comput Chem. 2013;34: 2135&#x2013;2145. 10.1002/jcc.23354</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.23354</ArticleId><ArticleId IdType="pmc">PMC3800559</ArticleId><ArticleId IdType="pubmed">23832629</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham MJ, Murtola T, Schulz R, P&#xe1;ll S, Smith JC, Hess B, et al.. Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1&#x2013;2: 19&#x2013;25. 10.1016/j.softx.2015.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.softx.2015.06.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Frisch M. J.; Trucks G. W.; Schlegel H. B.; Scuseria G. E.; Robb M. A.; Cheeseman J. R.; et al.. Gaussian 16, Revision C. 01. Gaussian, Inc., Wallingford CT. 2016. Available: https://gaussian.com/citation/.</Citation></Reference><Reference><Citation>Roothaan CCJ. New developments in molecular orbital theory. Rev Mod Phys. 1951;23: 69&#x2013;89. 10.1103/RevModPhys.23.69</Citation><ArticleIdList><ArticleId IdType="doi">10.1103/RevModPhys.23.69</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon MS, Binkley JS, Pople JA, Pietro WJ, Hehre WJ. Self-consistent molecular-orbital methods. 22. Small split-valence basis sets for second-row elements. J Am Chem Soc. 1982;104: 2797&#x2013;2803. 10.1021/ja00374a017</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja00374a017</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Truhlar DG. The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: Two new functionals and systematic testing of four M06-class functionals and 12 other function. Theor Chem Acc. 2008;120: 215&#x2013;241. 10.1007/s00214-007-0310-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00214-007-0310-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan R, Binkley JS, Seeger R, Pople JA. Self&#x2010;consistent molecular orbital methods. XX. A basis set for correlated wave functions. J Chem Phys. 1980;72: 650&#x2013;654. 10.1063/1.438955</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/1.438955</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolinski K, Hinton JF, Pulay P. Efficient implementation of the gauge-independent atomic orbital method for NMR chemical shift calculations. J Am Chem Soc. 1990;112: 8251&#x2013;8260. 10.1021/ja00179a005</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja00179a005</ArticleId></ArticleIdList></Reference><Reference><Citation>LeVatte MA, Lipfert M, Ladner-Keay C, Wishart DS. Preparation and characterization of a highly soluble A&#x3b2;1&#x2013;42 peptide variant. Protein Expr Purif. 2019;164: 105480. 10.1016/j.pep.2019.105480</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pep.2019.105480</ArticleId><ArticleId IdType="pubmed">31425755</ArticleId></ArticleIdList></Reference><Reference><Citation>Ames GF, Prody C, Kustu S. Simple, rapid, and quantitative release of periplasmic proteins by chloroform. J Bacteriol. 1984;160: 1181&#x2013;1183. 10.1128/JB.160.3.1181-1183.1984</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JB.160.3.1181-1183.1984</ArticleId><ArticleId IdType="pmc">PMC215841</ArticleId><ArticleId IdType="pubmed">6501229</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L, Bertini I, Cantini F, D&#x2019;Amelio N, Gaggelli E. Human SOD1 before harboring the catalytic metal: Solution structure of copper-depleted, disulfide-reduced form. J Biol Chem. 2006;281: 2333&#x2013;2337. 10.1074/jbc.M506497200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M506497200</ArticleId><ArticleId IdType="pubmed">16291742</ArticleId></ArticleIdList></Reference><Reference><Citation>Tachu BJ, W&#xfc;sten KA, Garza MC, Wille H, Tamg&#xfc;ney G. An easy method for bacterial expression and purification of wild-type and mutant superoxide dismutase 1 (SOD1). Protein Expr Purif. 2017;134: 63&#x2013;71. 10.1016/j.pep.2017.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pep.2017.04.001</ArticleId><ArticleId IdType="pubmed">28385582</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin F, Yan D, Chen Y, Emmanuella EF, Shi H, Han B, et al.. Cloning, purification and enzymatic characterization of recombinant human superoxide dismutase 1 (hSOD1) expressed in Escherichia coli. Acta Biochim Pol. 2018;65: 235&#x2013;240. 10.18388/abp.2017_2350</Citation><ArticleIdList><ArticleId IdType="doi">10.18388/abp.2017_2350</ArticleId><ArticleId IdType="pubmed">29850654</ArticleId></ArticleIdList></Reference><Reference><Citation>Porcheron G, Gar&#xe9;naux A, Proulx J, Sabri M, Dozois CM. Iron, copper, zinc, and manganese transport and regulation in pathogenic Enterobacteria: Correlations between strains, site of infection and the relative importance of the different metal transport systems for virulence. Front Cell Infect Microbiol. 2013;3: 90. 10.3389/fcimb.2013.00090</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2013.00090</ArticleId><ArticleId IdType="pmc">PMC3852070</ArticleId><ArticleId IdType="pubmed">24367764</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandrangsu P, Rensing C, Helmann JD. Metal homeostasis and resistance in bacteria. Nat Rev Microbiol. 2017;15: 338&#x2013;350. 10.1038/nrmicro.2017.15</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2017.15</ArticleId><ArticleId IdType="pmc">PMC5963929</ArticleId><ArticleId IdType="pubmed">28344348</ArticleId></ArticleIdList></Reference><Reference><Citation>Outten FW, Huffman DL, Hale JA, O&#x2019;Halloran TV. The Independent cue and cus Systems Confer Copper Tolerance during Aerobic and Anaerobic Growth in Escherichia coli. J Biol Chem. 2001;276: 30670&#x2013;30677. 10.1074/jbc.M104122200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M104122200</ArticleId><ArticleId IdType="pubmed">11399769</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirsten A, Herzberg M, Voigt A, Seravalli J, Grass G, Scherer J, et al.. Contributions of five secondary metal uptake systems to metal homeostasis of Cupriavidus metallidurans CH34. J Bacteriol. 2011;193: 4652&#x2013;4663. 10.1128/JB.05293-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JB.05293-11</ArticleId><ArticleId IdType="pmc">PMC3165648</ArticleId><ArticleId IdType="pubmed">21742896</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan S, Hiniker A, Collet JF, Bardwell JCA. Isolation of bacteria envelope proteins. Methods Mol Biol. 2013;966: 359&#x2013;366. 10.1007/978-1-62703-245-2_22</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-62703-245-2_22</ArticleId><ArticleId IdType="pubmed">23299746</ArticleId></ArticleIdList></Reference><Reference><Citation>OpenWetWare. [cited 1 Dec 2020]. Available: https://openwetware.org/wiki/E._coli_genotypes.</Citation></Reference><Reference><Citation>Antonyuk S, Strange RW, Hasnain SS. Structural discovery of small molecule binding sites in Cu-Zn human superoxide dismutase familial amyotrophic lateral sclerosis mutants provides insights for lead optimization. J Med Chem. 2010;53: 1402&#x2013;1406. 10.1021/jm9017948</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm9017948</ArticleId><ArticleId IdType="pubmed">20067275</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjula R, Wright GSA, Strange RW, Padmanabhan B. Assessment of ligand binding at a site relevant to SOD1 oxidation and aggregation. FEBS Lett. 2018;592: 1725&#x2013;1737. 10.1002/1873-3468.13055</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13055</ArticleId><ArticleId IdType="pubmed">29679384</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>